Subject : Hanall Biopharma Acquires Patent for Atopy Medicine
Date
2010-10-29
Visit
4487
Hanall Biopharma announced that it acquired a patent for ‘compositions for external application, containing adenosylcobalamin for improvement of skin diseases’ directed at treating atopy skin disease.
Hanall Biopharma spokesperson explained that the pharmaceutical company is currently in 2nd round of clinical testing in South Korea and that it is preparing for its 2nd round of clinical testing for the Food and Drug Administration in the United States as well.
DOWON INTERNATIONAL
5F. Shinwon Bldg. 823-14, Yeoksam-dong, Kangnam-ku, SEOUL, 135-080
KOREA
PHONE : 82-2-501-3106 FAX : 82-2-501-3109 e-mail : patyellow@dowon.com
Patent News
